GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteonomix Inc (OTCPK:PROT) » Definitions » EV-to-FCF

PROT (Proteonomix) EV-to-FCF : 0.00 (As of Apr. 28, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Proteonomix EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Proteonomix's Enterprise Value is $0.00 Mil. Proteonomix's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2012 was $-1.32 Mil. Therefore, Proteonomix's EV-to-FCF for today is 0.00.

The historical rank and industry rank for Proteonomix's EV-to-FCF or its related term are showing as below:

PROT's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 2.28
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-28), Proteonomix's stock price is $1.0E-5. Proteonomix's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2012 was $-0.390. Therefore, Proteonomix's PE Ratio (TTM) for today is At Loss.


Proteonomix EV-to-FCF Historical Data

The historical data trend for Proteonomix's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteonomix EV-to-FCF Chart

Proteonomix Annual Data
Trend Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec08 Dec09 Dec10 Dec11
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.14 -190.37 -32.36 -8.69 -21.79

Proteonomix Quarterly Data
Mar02 Jun02 Sep02 Dec02 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Proteonomix's EV-to-FCF

For the Biotechnology subindustry, Proteonomix's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteonomix's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteonomix's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Proteonomix's EV-to-FCF falls into.


;
;

Proteonomix EV-to-FCF Calculation

Proteonomix's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-1.318
=0.00

Proteonomix's current Enterprise Value is $0.00 Mil.
Proteonomix's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteonomix  (OTCPK:PROT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Proteonomix's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.0E-5/-0.390
=At Loss

Proteonomix's share price for today is $1.0E-5.
Proteonomix's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.390.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Proteonomix EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Proteonomix's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteonomix Business Description

Traded in Other Exchanges
N/A
Address
140 East Ridgewood Avenue, Suite 415, Paramus, NJ, USA, 07652
Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company focuses on developing therapeutics based upon the use of human cells and their derivative.
Executives
Roger Fidler director 400 GROVE STREET, GLEN ROCK NJ 07452

Proteonomix Headlines

No Headlines